| |
| |
|
| Insider
Information: |
Evnin Luke |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
15 |
|
| Direct
Shares |
330,044 |
|
|
Indirect Shares
|
35,767,143 |
|
|
| Direct
Value |
$449,921 |
|
|
|
Indirect Value
|
$125,579,860 |
|
|
| Total
Shares |
36,097,187 |
|
|
| Total
Value |
$126,029,782 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -18.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
|
0 |
2006-01-05 |
2,272,935 |
Premium* |
|
|
Idenix Pharmaceuticals Inc |
IDIX |
10% Owner |
2004-07-27 |
0 |
2004-07-27 |
4,797,991 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2004-07-02 |
0 |
2004-07-02 |
1,833,597 |
Premium* |
|
|
iPass Inc |
IPAS |
10% Owner |
2004-02-09 |
26,043 |
2004-02-09 |
262,533 |
Premium* |
|
|
Hemosense Inc |
HEM |
10% Owner |
2005-07-01 |
0 |
2007-11-06 |
0 |
Premium* |
|
|
American Cryostem Corporation |
CRYO |
10% Owner |
2005-07-13 |
0 |
2005-07-19 |
2,931,531 |
Premium* |
|
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
|
0 |
2016-09-27 |
3,887,502 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-13 |
0 |
2013-06-13 |
824,255 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
Director, 10% Owner |
2016-03-08 |
0 |
2016-03-08 |
2,168,691 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
Former 10% Owner |
2019-02-12 |
0 |
2021-04-15 |
3,220,844 |
Premium* |
|
|
Repare Therapeutics Inc. |
RPTX |
10% Owner |
2020-06-23 |
0 |
2020-06-23 |
3,003,772 |
Premium* |
|
|
Oncorus, Inc. |
ONCR |
Director, 10% Owner |
|
0 |
2020-10-06 |
2,492,843 |
Premium* |
|
|
Turmeric Acquisition Corp. |
TMPM |
Chief Executive Officer |
2020-10-20 |
0 |
2020-10-20 |
415,500 |
Premium* |
|
|
Werewolf Therapeutics, Inc. |
HOWL |
Director, 10% Owner |
|
0 |
2021-05-04 |
4,284,172 |
Premium* |
|
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-22 |
304,001 |
2023-05-22 |
3,370,977 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRYO |
American Cryostem Corpora... |
10% Owner |
– – • |
2005-07-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(92,790) |
2,931,531 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-30 |
4 |
S |
$2.28 |
$228,000 |
I/I |
(100,000) |
6,287,050 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-09-09 |
4 |
S |
$2.51 |
$250,980 |
I/I |
(100,000) |
4,445,050 |
|
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
– – • |
2021-01-20 |
4 |
AS |
$0.00 |
$0 |
I/I |
(101,646) |
4,405,085 |
0 |
% |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-09-16 |
4 |
AS |
$2.41 |
$252,588 |
I/I |
(105,000) |
4,061,075 |
|
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-04-23 |
4 |
AS |
$30.00 |
$3,243,450 |
I/I |
(108,115) |
1,169,789 |
0 |
- |
|
| CRYO |
American Cryostem Corpora... |
10% Owner |
– – • |
2005-07-19 |
4 |
OE |
$8.37 |
$1,020,638 |
I/I |
121,940 |
3,024,321 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
– • – |
2005-12-27 |
4 |
AS |
$2.32 |
$301,080 |
I/I |
(130,000) |
2,446,935 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Former 10% owner |
– • – |
2005-08-16 |
4 |
S |
$2.64 |
$396,360 |
I/I |
(150,000) |
7,332,050 |
|
- |
|
| HOWL |
Werewolf Therapeutics, In... |
Director |
– • • |
2021-05-04 |
4 |
B |
$16.00 |
$2,412,784 |
I/I |
150,799 |
4,284,172 |
2.25 |
- |
|
| ONCR |
Oncorus, Inc. |
Director |
– • • |
2020-10-06 |
4 |
B |
$15.00 |
$2,268,375 |
I/I |
151,225 |
2,492,843 |
2.25 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Former 10% owner |
– • – |
2005-08-17 |
4 |
S |
$2.66 |
$425,840 |
I/I |
(160,000) |
7,172,050 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-19 |
4 |
S |
$2.35 |
$383,168 |
I/I |
(160,000) |
6,787,050 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
– • – |
2005-12-16 |
4 |
AS |
$2.30 |
$395,600 |
I/I |
(172,000) |
3,565,535 |
|
- |
|
| HEM |
Hemosense Inc |
10% Owner |
– – • |
2007-09-13 |
4 |
S |
$12.79 |
$2,235,692 |
I/I |
(174,800) |
3,828,319 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2023-05-22 |
4 |
OE |
$0.74 |
$131,919 |
D/D |
178,269 |
374,171 |
0 |
- |
|
| CRYO |
American Cryostem Corpora... |
10% Owner |
– – • |
2005-07-13 |
4 |
B |
$11.00 |
$1,980,000 |
I/I |
180,000 |
180,000 |
1.5 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
– – • |
2021-02-10 |
4 |
AS |
$20.00 |
$3,661,020 |
I/I |
(183,051) |
3,238,306 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-05-28 |
4 |
AS |
$30.62 |
$6,039,523 |
I/I |
(195,117) |
981,255 |
0 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-22 |
4 |
S |
$2.28 |
$456,680 |
I/I |
(200,000) |
6,587,050 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-24 |
4 |
S |
$2.23 |
$446,000 |
I/I |
(200,000) |
6,387,050 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-09-12 |
4 |
S |
$2.44 |
$500,938 |
I/I |
(205,000) |
4,240,050 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-08-18 |
4 |
S |
$2.53 |
$569,160 |
I/I |
(225,000) |
6,947,050 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
– • – |
2005-12-15 |
4 |
AS |
$2.32 |
$534,135 |
I/I |
(230,300) |
3,737,535 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-09-06 |
4 |
S |
$2.47 |
$602,046 |
I/I |
(242,000) |
4,545,050 |
|
- |
|
107 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
